Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Prepaid Assets (2021 - 2025)

Stoke Therapeutics has reported Prepaid Assets over the past 5 years, most recently at $3.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 64.96% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.9 million, down 64.96%, while the annual FY2025 figure was $3.9 million, 64.96% down from the prior year.
  • Prepaid Assets for Q4 2025 was $3.9 million at Stoke Therapeutics, down from $5.5 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $13.7 million in Q2 2025 and troughed at $2.2 million in Q4 2021.
  • A 5-year average of $7.3 million and a median of $5.5 million in 2025 define the central range for Prepaid Assets.
  • Biggest five-year swings in Prepaid Assets: crashed 71.93% in 2023 and later soared 334.09% in 2024.
  • Year by year, Prepaid Assets stood at $2.2 million in 2021, then soared by 33.35% to $3.0 million in 2022, then decreased by 13.33% to $2.6 million in 2023, then soared by 334.09% to $11.1 million in 2024, then crashed by 64.96% to $3.9 million in 2025.
  • Business Quant data shows Prepaid Assets for STOK at $3.9 million in Q4 2025, $5.5 million in Q3 2025, and $13.7 million in Q2 2025.